The U.S. Food and Drug Administration (FDA) has approved a mineral water filtrate that it says may help reduce waterborne infections.
The FDA said in a news release that the filtrates “can reduce the incidence of waterborne bacteria by up to 50 percent.”
It also says the filtates may help prevent other waterborne illnesses.
“The filtration of water for human use may pose risks to the health of individuals, including those who are exposed to contaminated water, such as individuals who are in contact with children,” the FDA said.
The agency said it is awaiting approval from a state-licensed water filtlate manufacturer to distribute the filters to consumers.
The product, called Nexium, is a mix of the two types of filtrate that the FDA approved earlier this year.
The EPA has approved Nexium as a water filtic water disinfectant, which is similar to the water disinfection agents that are used to treat sewage and other wastewater.
The company said the filtlates could be used in the treatment of water systems to treat wastewater, or to prevent the spread of water-borne viruses.
It also said the product has not yet been tested in humans.
The Nexium filtric acid is made with magnesium silicate, which has antimicrobial properties.
The FDA said the Nexium is “available to the public” for purchase online, but only in limited quantities and in a limited number of formulations.
It’s not clear how many people have already purchased the product.
The new mineral water filters have a three-year shelf life, according to the FDA.
Dr. Mark Stoltenberg, a water treatment expert and former director of the Centers for Disease Control and Prevention, told NBC News that the water filters “are going to be very helpful for a lot of people, but they’re going to cause some concern for some people.
I think the biggest concern is that some people are going to become infected.”
He said it’s “very, very important” to monitor the water supply.
Health officials have been pushing for the use of filtrators to combat waterborne illness, especially among pregnant women and children.
FDA’s new regulations are being challenged in court by the state of New Jersey, which says the new filtriers do not qualify as a medical device under state law.
The lawsuit was filed last month in federal court in Newark.
The company that makes Nexium declined to comment on the lawsuit, but said in an email that it “supports the safety of the filter in its current formulation.”